Literature DB >> 33124967

Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.

Xanthe L Strudwick1, Damian H Adams1, Natasha T Pyne2, Michael S Samuel2,3, Rachael Z Murray4, Allison J Cowin1.   

Abstract

Objective: Increased macrophage recruitment in the early stages of wound healing leads to an excessive inflammatory response associated with elevated fibrosis and scarring. This recruitment relies upon integrins on the surface of monocytes that regulate their migration and extravasation from the circulation into the wound site, where they differentiate into macrophages. The aim of this study was to determine if inhibiting monocyte extravasation from the circulation into burns would reduce macrophages numbers in burns and lead to reduced inflammation and scar formation. Approach: Scald burns were created on mice and treated with integrin alpha L (αL) function blocking antibody via intravenous delivery day 1 after injury. The effect of inhibiting macrophage recruitment into the burn was assessed using macro- and microscopic wound parameters as well as immunohistochemistry for inflammatory cell markers, cytokines, and collagen deposition.
Results: Burn wound-associated macrophages were reduced by 54.7% at day 3 following treatment with integrin αL antibody, with levels returning to normal by day 7. This reduction in macrophages led to a concomitant reduction in inflammatory mediators, including tumor necrosis factor-alpha (TNFα) and Il-10 as well as a reduction in proscarring transforming growth factor beta 1 (TGFβ1). This reduced inflammatory response was also associated with less alpha smooth muscle actin (αSMA) expression and an overall trend toward reduced scar formation with a lower collagen I/III ratio. Innovation: Treatment of burns with integrin αL function blocking antibodies reduces inflammation in burn wounds.
Conclusion: These results suggest that reducing macrophage infiltration into burn wounds may lead to a reduced early inflammatory response and less scar formation following burn injury.

Entities:  

Keywords:  TGFβ1; TNFα; burns; integrin; macrophage

Year:  2020        PMID: 33124967      PMCID: PMC7698651          DOI: 10.1089/wound.2019.1035

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  35 in total

Review 1.  Inflammation in wound repair: molecular and cellular mechanisms.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  J Invest Dermatol       Date:  2007-03       Impact factor: 8.551

2.  Differential roles of macrophages in diverse phases of skin repair.

Authors:  Tina Lucas; Ari Waisman; Rajeev Ranjan; Jürgen Roes; Thomas Krieg; Werner Müller; Axel Roers; Sabine A Eming
Journal:  J Immunol       Date:  2010-02-22       Impact factor: 5.422

3.  Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation.

Authors:  Thorsten Peters; Anca Sindrilaru; Boris Hinz; Ralf Hinrichs; André Menke; Ezz Al Din Al-Azzeh; Katrin Holzwarth; Tsvetelina Oreshkova; Honglin Wang; Daniel Kess; Barbara Walzog; Silke Sulyok; Cord Sunderkötter; Wilhelm Friedrich; Meinhard Wlaschek; Thomas Krieg; Karin Scharffetter-Kochanek
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

Review 4.  Skin wound healing in humans and mice: Challenges in translational research.

Authors:  Helena D Zomer; Andrea G Trentin
Journal:  J Dermatol Sci       Date:  2017-12-26       Impact factor: 4.563

Review 5.  Wound macrophages as key regulators of repair: origin, phenotype, and function.

Authors:  Samielle K Brancato; Jorge E Albina
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing.

Authors:  Gillian S Ashcroft; Moon-Jin Jeong; Jason J Ashworth; Matthew Hardman; Wenwen Jin; Niki Moutsopoulos; Teresa Wild; Nancy McCartney-Francis; Davis Sim; George McGrady; Xiao-Yu Song; Sharon M Wahl
Journal:  Wound Repair Regen       Date:  2011-12-08       Impact factor: 3.617

Review 7.  Efalizumab.

Authors:  Marina Talamonti; Giulia Spallone; Alessandro Di Stefani; Antonio Costanzo; Sergio Chimenti
Journal:  Expert Opin Drug Saf       Date:  2011-01-10       Impact factor: 4.250

8.  LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function.

Authors:  Natalie M Reisman; Tamara L Floyd; Maylene E Wagener; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Blood       Date:  2011-10-04       Impact factor: 22.113

9.  Flightless I is a key regulator of the fibroproliferative process in hypertrophic scarring and a target for a novel antiscarring therapy.

Authors:  A M Cameron; C T Turner; D H Adams; J E Jackson; E Melville; R M Arkell; P J Anderson; A J Cowin
Journal:  Br J Dermatol       Date:  2016-01-09       Impact factor: 9.302

10.  Burn wound: How it differs from other wounds?

Authors:  V K Tiwari
Journal:  Indian J Plast Surg       Date:  2012-05
View more
  1 in total

Review 1.  Innate Immune System Response to Burn Damage-Focus on Cytokine Alteration.

Authors:  Olga Sierawska; Paulina Małkowska; Cansel Taskin; Rafał Hrynkiewicz; Paulina Mertowska; Ewelina Grywalska; Tomasz Korzeniowski; Kamil Torres; Agnieszka Surowiecka; Paulina Niedźwiedzka-Rystwej; Jerzy Strużyna
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.